Novonesis (0Q4U) Share Forecast & Price Target

Compare

11 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0Q4U Analyst Ratings

Moderate Buy

7 Buy

1 Hold

1 Sell

Based on 9 analysts giving stock ratings to

Novonesis

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0Q4U Stock 12 Month Forecast

Average Price Target

kr466.22

▲(21.87% Upside)

Based on 9 Wall Street analysts offering 12 month price targets for Novonesis in the last 3 months. The average price target is kr466.22 with a high forecast of kr569.00 and a low forecast of kr380.00. The average price target represents a 21.87% change from the last price of kr382.55.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"379":"kr379","570":"kr570","426.75":"kr426.8","474.5":"kr474.5","522.25":"kr522.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":569,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">kr569.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":466.22,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">kr466.22</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":380,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">kr380.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[379,426.75,474.5,522.25,570],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,405.44,418.02153846153846,430.6030769230769,443.18461538461537,455.7661538461538,468.3476923076923,480.9292307692308,493.51076923076926,506.0923076923077,518.6738461538462,531.2553846153846,543.8369230769231,556.4184615384615,{"y":569,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,405.44,410.11538461538464,414.79076923076923,419.4661538461539,424.14153846153846,428.8169230769231,433.4923076923077,438.16769230769233,442.8430769230769,447.51846153846157,452.19384615384615,456.8692307692308,461.5446153846154,{"y":466.22,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,405.44,403.4830769230769,401.5261538461538,399.5692307692308,397.6123076923077,395.6553846153846,393.6984615384615,391.7415384615385,389.7846153846154,387.8276923076923,385.8707692307692,383.9138461538462,381.9569230769231,{"y":380,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":418.03,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":434.31,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":464.48,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":477.78,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":426.52,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":414.45,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":408.03,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":429.89,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":400.3,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":428.86,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":466.67,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":418.34,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":405.44,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Targetkr569.00

Average Price Targetkr466.22

Lowest Price Targetkr380.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Thomas Wrigglesworth

Morgan Stanley

kr569

Buy

48.74%

Upside

Reiterated

09/30/25

Novonesis (0Q4U) Receives a Buy from Morgan StanleyMorgan Stanley analyst Thomas Wrigglesworth reiterated an Overweight rating and DKK569.00 price target on Novonesis A/S (NSISB:DC).

Charles Eden

UBS

kr470→kr445

Buy

16.32%

Upside

Reiterated

09/30/25

Novonesis (0Q4U): New Buy Recommendation for This Technology Giant

Alex Sloane

Barclays

kr470→kr460

Buy

20.25%

Upside

Reiterated

09/30/25

New Buy Rating for Novonesis (0Q4U), the Technology Giant

Virginie Boucher-Ferte

Deutsche Bank

kr490→kr480

Buy

25.47%

Upside

Reiterated

09/24/25

Novonesis (0Q4U): New Buy Recommendation for This Technology Giant

Patrick Roquas

Kepler Capital

kr415

Hold

8.48%

Upside

Reiterated

09/09/25

Kepler Capital Reaffirms Their Hold Rating on Novonesis (0Q4U)

Chetan Udeshi

J.P. Morgan

kr545→kr512

Buy

33.84%

Upside

Reiterated

08/27/25

Novonesis (0Q4U): New Buy Recommendation for This Technology Giant

Sebastian Bray

Berenberg Bank

kr530→kr465

Buy

21.55%

Upside

Reiterated

08/26/25

New Buy Rating for Novonesis (0Q4U), the Technology Giant

Charles Bentley, CFA

Jefferies

kr540→kr470

Buy

22.86%

Upside

Reiterated

08/24/25

New Buy Rating for Novonesis (0Q4U), the Technology Giant

Ranulf Orr

Citi

kr400→kr380

Sell

-0.67%

Downside

Reiterated

08/22/25

Citi Reaffirms Their Sell Rating on Novonesis (0Q4U)

Adrian Ng

CFRA

kr450

Hold

17.63%

Upside

Reiterated

03/07/25

CFRA Reiterates Hold Rating on Novonesis A/S (NSISB:DC)CFRA analyst Adrian Ng reiterated a Hold rating and DKK450.00 price target on Novonesis A/S (NSISB:DC).

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Thomas Wrigglesworth

Morgan Stanley

kr569

Buy

48.74%

Upside

Reiterated

09/30/25

Novonesis (0Q4U) Receives a Buy from Morgan StanleyMorgan Stanley analyst Thomas Wrigglesworth reiterated an Overweight rating and DKK569.00 price target on Novonesis A/S (NSISB:DC).

Charles Eden

UBS

kr470→kr445

Buy

16.32%

Upside

Reiterated

09/30/25

Novonesis (0Q4U): New Buy Recommendation for This Technology Giant

Alex Sloane

Barclays

kr470→kr460

Buy

20.25%

Upside

Reiterated

09/30/25

New Buy Rating for Novonesis (0Q4U), the Technology Giant

Virginie Boucher-Ferte

Deutsche Bank

kr490→kr480

Buy

25.47%

Upside

Reiterated

09/24/25

Novonesis (0Q4U): New Buy Recommendation for This Technology Giant

Patrick Roquas

Kepler Capital

kr415

Hold

8.48%

Upside

Reiterated

09/09/25

Kepler Capital Reaffirms Their Hold Rating on Novonesis (0Q4U)

Chetan Udeshi

J.P. Morgan

kr545→kr512

Buy

33.84%

Upside

Reiterated

08/27/25

Novonesis (0Q4U): New Buy Recommendation for This Technology Giant

Sebastian Bray

Berenberg Bank

kr530→kr465

Buy

21.55%

Upside

Reiterated

08/26/25

New Buy Rating for Novonesis (0Q4U), the Technology Giant

Charles Bentley, CFA

Jefferies

kr540→kr470

Buy

22.86%

Upside

Reiterated

08/24/25

New Buy Rating for Novonesis (0Q4U), the Technology Giant

Ranulf Orr

Citi

kr400→kr380

Sell

-0.67%

Downside

Reiterated

08/22/25

Citi Reaffirms Their Sell Rating on Novonesis (0Q4U)

Adrian Ng

CFRA

kr450

Hold

17.63%

Upside

Reiterated

03/07/25

CFRA Reiterates Hold Rating on Novonesis A/S (NSISB:DC)CFRA analyst Adrian Ng reiterated a Hold rating and DKK450.00 price target on Novonesis A/S (NSISB:DC).

Stocks with the Highest Top Analyst Consensus in the Technology Sector

xxx

Find stocks in the Technology sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Novonesis

1 Month

xxx

Success Rate

13/17 ratings generated profit

Average Return

+1.22%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 76.47% of your transactions generating a profit, with an average return of +1.22% per trade.

3 Months

xxx

Success Rate

10/17 ratings generated profit

Average Return

+3.86%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 58.82% of your transactions generating a profit, with an average return of +3.86% per trade.

1 Year

Charles EdenUBS

Success Rate

10/16 ratings generated profit

Average Return

+8.04%

reiterated a buy rating 2 days ago

Copying Charles Eden's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +8.04% per trade.

2 Years

xxx

Success Rate

11/16 ratings generated profit

Average Return

+9.66%

reiterated a xxx

rating 2 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 68.75% of your transactions generating a profit, with an average return of +9.66% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0Q4U Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Aug 25

Sep 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0Q4U has received 13 Buy Ratings, 5 Hold Ratings, and 1 Sell Ratings. 0Q4U average Analyst price target in the past 3 months is 466.22.

Each month's total comprises the sum of three months' worth of ratings.

0Q4U Financial Forecast

0Q4U Earnings Forecast

Next quarter’s earnings estimate for 0Q4U is kr4.17 with a range of kr2.74 to kr6.57. The previous quarter’s EPS was kr2.69. 0Q4U beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 67.18% of the time in the same period. In the last calendar year 0Q4U has Preformed in-line its overall industry.

0Q4U Sales Forecast

Next quarter’s sales forecast for 0Q4U is kr7.98B with a range of kr7.85B to kr8.09B. The previous quarter’s sales results were kr7.60B. 0Q4U beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 70.58% of the time in the same period. In the last calendar year 0Q4U has Preformed in-line its overall industry.

0Q4U Stock Forecast FAQ

What is GB:0Q4U’s average 12-month price target, according to analysts?

Based on analyst ratings, Novonesis A/S (UK)’s 12-month average price target is 466.22.

What is GB:0Q4U’s upside potential, based on the analysts’ average price target?

Novonesis A/S (UK) has 21.87% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Novonesis A/S (UK) a Buy, Sell or Hold?

Novonesis A/S (UK) has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 1 hold ratings and 1 sell ratings.

What is Novonesis A/S (UK)’s share price target?

The average share price target for Novonesis A/S (UK) is 466.22. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is kr569.00 ,and the lowest forecast is kr380.00. The average share price target represents 21.87% Increase from the current price of kr382.55.

What do analysts say about Novonesis A/S (UK)?

Novonesis A/S (UK)’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.

How can I buy shares of Novonesis A/S (UK)?

To buy shares of GB:0Q4U, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Novonesis (0Q4U) Share Forecast & Price Target

0Q4U Analyst Ratings

0Q4U Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Novonesis

0Q4U Analyst Recommendation Trends

0Q4U Financial Forecast

0Q4U Earnings Forecast

0Q4U Sales Forecast

0Q4U Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts